The in vitro data clearly indicated that interfering with HMGB1 via siRNA or inhibiting it with EP significantly reduced HMGB1 expression in MM cells, accompanied by corresponding reductions in migration, and invasion. This evidence concerns the gene HMGB1 and Miyoshi myopathy.